바로가기메뉴

본문 바로가기 주메뉴 바로가기

옥트레오타이드를 이용한 유육종증과 동반된 유미흉의 보존적 치료 1예

A Case of Successful Management of Sarcoidosis with Chylothorax Using Octreotide

Tuberculosis & Respiratory Diseases / Tuberculosis & Respiratory Diseases,
2007, v.62 no.2, pp.119-124
정경수 (연세의대)
김영삼 (연세대학교)
김세규 (연세대학교)
김성규 (연세대학교)
장준 (연세대학교)
박무석 (연세대학교)
문지애 (연세의대)
윤설희 (연세의대)
변민광 (연세의대)
정우영 (연세의대)
정재희 (연세의대)
최상봉 (연세의대)
김대준 (연세의대)
표주연 (연세의대)
  • 다운로드 수
  • 조회수

Abstract

Sarcoidosis is a multi-system granulomatous disorder of an unknown etiology and affects individuals worldwide. It is characterized pathologically by the presence of non-caseating granulomas in more than one involved organ. However, pleural involvement of sarcoidosis is rare and there are no reported cases in Korea. Traditionally, sarcoidosis has often been treated with systemic corticosteroids or cytotoxic agents. In particular, chylothorax with sarcoidosis is usually treated with corticosteroid for approximately 3~6 months, followed by repeated therapeutic thoracentesis, talc pleurodesis, dietary treatment, or thoracic duct ligation where needed. We encountered a 46 years old female patient presenting with cough, dyspnea and both hilar lymphadenopathy (stage I) on chest radiograph. The patient was diagnosed with a non-caseating granuloma, sarcoidosis by a mediastinoscopic biopsy. For one month, she had suffered from dyspnea due to right side pleural effusion, which was clearly identified as a chylothorax on thoracentesis. Corticosteroid therapy with dietary adjustment was ineffective. She was treated successfully with a subcutaneous injection of octreotide for 3 weeks and oral corticosteroid. We report a case of successful and rapid treatment of chylothorax associated with sarcoidosis using octreotide and oral corticosteroid. (Tuberc Respir Dis 2007; 62: 119-124)

keywords
Sarcoidosis, Chylothorax, Pleural involvement, Octreotide, Mediastinoscopy., Sarcoidosis, Chylothorax, Pleural involvement, Octreotide, Mediastinoscopy.

참고문헌

1.

(1999) Statement on sarcoidosis: Joint Statement of the American Thoracic Society (ATS), the European Respiratory Society (ERS) and the World Association of Sarcoidosis and Other Granulomatous Disorder (WASOG) adopted by the ATS Board of Directors and by the ERS Executive Committee,

2.

complicated by chylothorax. Minn Med 1966,

3.

Phillips YY. Sarcoidosis complicated by chylothorax. South Med J 1994,

4.

(1995) Sarcoidosis presenting with chylothorax,

5.

(1995) Recurrent chylothorax associated with sarcoidosis,

6.

(1996) Chylothorax as a complication of sarcoidosis,

7.

(2000) Pleural involvement in sarcoidosis,

8.

(2004) Surgery for chylothorax,

9.

(1997) Chylothorax^pseudochylothorax,

10.

(2003) Octreotide as a therapeutic option for management of chylothorax,

11.

(2001) Somatostatin in the treatment of chylothorax,

12.

(2003) Chylous leak after cervical mediastinoscopy,

13.

Debesse B. Chylomediastinum after mediastinoscopy apropos of a case. Rev Mal Respir 1993,

14.

Klein W. Complications following mediastinoscopy,

Tuberculosis & Respiratory Diseases